| KLF10 |
KLF10, TIEG, TIEG1: Krueppel-like factor 10 |
HDAC1 |
HDAC1, RPD3L1: Histone deacetylase 1 |
3.295 |
Evidence |
|
| CCND2 |
CCND2: G1/S-specific cyclin-D2 |
BRCA1 |
BRCA1, RNF53: Breast cancer type 1 susceptibility protein |
3.295 |
Evidence |
|
| NCBP2 |
NCBP2, CBP20, PIG55: Nuclear cap-binding protein subunit 2 |
ZFP36L1 |
ZFP36L1, BERG36, BRF1, ERF1, RNF162B, TIS11B: Butyrate response factor 1 |
3.295 |
Evidence |
|
| MYBL2 |
MYBL2, BMYB: Myb-related protein B |
PAX5 |
PAX5: Paired box protein Pax-5 |
3.295 |
Evidence |
|
| GGA2 |
GGA2, KIAA1080: ADP-ribosylation factor-binding protein GGA2 |
GGA1 |
GGA1: GGA1 protein |
3.295 |
Evidence |
|
| GRIA1 |
GRIA1, GLUH1, GLUR1: Glutamate receptor 1 precursor |
KCNJ6 |
KCNJ6, GIRK2, KATP2, KCNJ7: G protein-activated inward rectifier potassium chann |
3.295 |
Evidence |
|
| CHN2 |
CHN2, ARHGAP3, BCH: Beta-chimaerin |
MYO3A |
MYO3A: Myosin IIIA |
3.295 |
Evidence |
|
| PIM1 |
IPI00005014 |
NCK1 |
NCK1, NCK: Cytoplasmic protein NCK1 |
3.295 |
Evidence |
|
| MAP2K2 |
MAP2K2, MEK2, MKK2, PRKMK2: Dual specificity mitogen-activated protein kinase ki |
ARAF |
ARAF, ARAF1, PKS, PKS2: A-Raf proto-oncogene serine/threonine-protein kinase |
3.285 |
Evidence |
O
|
| PRMT5 |
PRMT5, HRMT1L5, IBP72, JBP1, SKB1: Protein arginine N-methyltransferase 5 |
SNRPE |
SNRPE: Small nuclear ribonucleoprotein E |
3.285 |
Evidence |
|
| C9orf26 |
IL33, C9orf26, IL1F11, NFHEV: Interleukin-33 precursor |
MMP1 |
MMP1, CLG: Interstitial collagenase precursor |
3.285 |
Evidence |
|
| PCNA |
PCNA: Proliferating cell nuclear antigen |
CDCA8 |
CDCA8, PESCRG3: Borealin |
3.285 |
Evidence |
|
| SNRPE |
SNRPE: Small nuclear ribonucleoprotein E |
MRPL22 |
MRPL22, HSPC158: 39S ribosomal protein L22, mitochondrial precursor |
3.285 |
Evidence |
|
| SUMO1 |
SUMO1, SMT3C, OK/SW-cl.43, SMT3H3, UBL1: Small ubiquitin-related modifier 1 prec |
SERBP1 |
IPI00412714 |
3.285 |
Evidence |
|
| ADPRT |
PARP1, ADPRT, PPOL: Poly [ADP-ribose] polymerase 1 |
CALM2 |
CALM1, CALM, CALM2, CAM2, CALM3, CALML2, CAM, CAMB, CAM3, CAM1, CAMC, CAMIII: Ca |
3.282 |
Evidence |
|
| SFRS10 |
SFRS10, TRA2B: Splicing factor, arginine/serine-rich 10 |
SH3BP2 |
SH3BP2: Uncharacterized protein SH3BP2 |
3.28 |
Evidence |
|
| VAV1 |
VAV1, VAV: Proto-oncogene vav |
FCGR2A |
FCGR2A: Fc of IgG, low affinity IIa, receptor |
3.28 |
Evidence |
|
| NBN |
NBN, NBS, NBS1, P95: Nibrin |
TBCE |
TBCE: Tubulin-specific chaperone E |
3.28 |
Evidence |
|
| EIF3S8 |
EIF3S8: Eukaryotic translation initiation factor 3 subunit 8 |
HLA-DMA |
DMA, HLA-DMA, DAQB-96B10.1-001, DASS-67H14.8-001, XXbac-BCX136A3.1-001, XXbac-BP |
3.28 |
Evidence |
|
| RGS2 |
RGS2, G0S8: Regulator of G-protein signaling 2 |
IQGAP2 |
IQGAP2: Ras GTPase-activating-like protein IQGAP2 |
3.28 |
Evidence |
|
| RRAS |
RRAS: Ras-related protein R-Ras precursor |
TNFRSF1A |
TNFRSF1A, TNFAR, TNFR1: Tumor necrosis factor receptor superfamily member 1A pre |
3.28 |
Evidence |
|
| SH3BP2 |
SH3BP2: Uncharacterized protein SH3BP2 |
FCGR2A |
FCGR2A: Fc of IgG, low affinity IIa, receptor |
3.28 |
Evidence |
|
| FLNA |
FLNA, FLN, FLN1: Filamin-A |
LCP2 |
LCP2: Lymphocyte cytosolic protein 2 |
3.28 |
Evidence |
|
| ZNF217 |
ZNF217, ZABC1: Zinc finger protein 217 |
TYK2 |
TYK2: Non-receptor tyrosine-protein kinase TYK2 |
3.28 |
Evidence |
|
| IKBKG |
IKBKG, FIP3, NEMO: NF-kappa-B essential modulator |
EEF1A1 |
EEF1A1: Elongation factor 1-alpha |
3.28 |
Evidence |
|
-